Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:canBe |
analgesic
anti-inflammatory agent |
| gptkbp:CASNumber |
gptkb:486460-32-6
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:function |
fatty acid amide hydrolase inhibitor
|
| gptkbp:hasInChIKey |
QJQYQJQYQJQYQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C23H20F3N3O2
|
| gptkbp:hasSMILES |
CC1=NN(C2=C1C=CC(=C2)C3=CC=CC=C3)C(=O)NC4=CC=C(C=C4)C(F)(F)F
|
| https://www.w3.org/2000/01/rdf-schema#label |
486460-32-6
|
| gptkbp:molecularWeight |
427.42 g/mol
|
| gptkbp:name |
gptkb:PF-04457845
|
| gptkbp:PubChem_CID |
11616710
9798572 |
| gptkbp:bfsParent |
gptkb:Januvia
|
| gptkbp:bfsLayer |
5
|